Persistent symptoms after COVID-19 infection continue to affect millions of people worldwide, even as the number of acute ...
MASS-FIX versus standard methods to predict for PFS and OS among multiple myeloma patients participating on the STAMINA trial. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I.
Retrospective analysis of digital biomarker predictability of immune checkpoint inhibitor therapy outcomes in patients with NSCLC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results